Ranbaxy Laboratories is in speaks with Ind-Swift Labs

Indian medicine manufacturer Ranbaxy Laboratories is in speaks with Ind-Swift Labs to source ingredient to produce a generic version of Pfizer Inc.’s (PFE) Lipitor blood cholesterol medicine.

Ind-Swift vice chairman N. R. Munjal stated that the firm is talking about various choices to deliver intermediate or final active pharmaceutical raw materials atorvastatin to Ranbaxy.

Ranbaxy plans to release the cholesterol medicine in the United states. at the end of November, but regulatory and producing issues at the Indian firm have late FDA authorization for the medicine.

Be Sociable, Share!
Tags: ,

Stock Market Basics For Beginners

Type of share (stock)

Type of share (stock) Stocks are divided into two types there are common stock and preference stock The common share (ordinary shares), which give the right to ...…

Economic Times

Economic Times Economic Times is India biggest daily business newspaper. Economic Times furthermore stood 2nd place in entire world following the Wall Street Journal. Economic Times was ...…

Definition for Stock

Definition for Stock The stock of a business entity represents the original capital  invested (paid into) in the business by its founders. The corporation ownership is determined by ...…

What IS a Share?

What IS a Share? [ad name="468x15- 5 link"] share is a unit of account for various financial instruments including mutual funds, stocks, limited partnerships, and REIT's. In simple Words, stock ...…

What is Lock-in?

What is Lock-in? "Lock-in" implies a freeze on the shares sale for a several time period. SEBI rules have stipulated lock-in needs on stocks of promoters mainly to ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics